发表一篇学和医学成像类SCI论文
需要多少钱?
Abstract:
BACKGROUND & AIMS:The intestine regulates glucose homeostasis, but it is not clear whether chronic intestinal inflammation affects risk for type 2 diabetes. We investigated the long-term risk of type 2 diabetes in patients with inflammatory bowel diseases (IBD) in a nationwide cohort study in Denmark. METHODS:In a nationwide population-based cohort of 6,028,844 persons in Denmark, we compared data from individuals with a diagnosis of IBD (Crohn's disease [CD] or ulcerative colitis UC]) with data from individuals from the general population from 1977 through 2014. Persons with type 2 diabetes were identified in the National Patient Register. Risk is presented as standardized incidence ratios (SIR) with 95% CIs. RESULTS:During 736,072 person-years of follow-up, 3436 patients with IBD developed type 2 diabetes vs 2224 expected (SIR, 1.54; 95% CI, 1.49-1.60). The risk was significantly increased in patients with UC (SIR, 1.54; 95% CI, 1.48-1.60), in patients with CD (SIR, 1.57; 95% CI, 1.47-1.67), in women (SIR, 1.51; 95% CI, 1.44-1.59), and in men (SIR, 1.57; 95% CI, 1.50-1.65). The risk was highest the first year after a diagnosis of IBD (SIR, 4.48; 95% CI, 4.16-4.83), but remained increased for 20 or more years following the diagnosis (SIR, 1.26; 95% CI, 1.16-1.38). The increased risk could not be accounted for by frequency of health care contacts or corticosteroid exposure. Patients who received a diagnosis of IBD from 2003 through 2014 (SIR, 1.79; 95% CI, 1.67-1.91) had a significantly higher risk of type 2 diabetes than patients who received a diagnosis of IBD from 1977 through 1988 (SIR, 1.47; 95% CI, 1.39-1.56) or 1989 through 2002 (SIR, 1.48; 95% CI, 1.41-1.56) (P < .001). CONCLUSIONS:In a population-based cohort study, we found an increased risk of type 2 diabetes in patients with UC or CD, with highest risk estimates from 2003 through 2014, compared with earlier years. Studies are needed to determine the effects of IBD treatment on risk of type 2 diabetes.
展开更多
最新影响因子:13.576 | 期刊ISSN:1542-3565 | CiteScore:3.75 |
出版周期:Monthly | 是否OA:YES | 出版年份:2003 |
期刊官方网址:http://www.journals.elsevier.com/clinical-gastroenterology-and-hepatology
自引率:5.50% | 研究方向:医学-胃肠肝病学 |
出版地区:UNITED STATES |
SCI期刊coverage:Science Citation Index Expanded(科学引文索引扩展)
专业编辑在线一对一答疑及时解决您的问题
Published by Elsevier Health. ISSN: 1542-3565. The mission of Clinical Gastroenterology and Hepatology (CGH) is to provide readers with a broad spectrum of themes in clinical gastroenterology and hepatology, including the diagnostic, endoscopic, interventional, and therapeutic advances in cancer, inflammatory diseases, functional gastrointestinal disorders, nutrition, absorption, and secretion. This peer-reviewed journal includes original articles as well as scholarly reviews, with the goal that all articles published will be immediately relevant to practice of the specialties of gastroenterology and hepatology. In addition to peer-reviewed articles, the journal includes invited key reviews and articles on endoscopy/practice-based technology, health-care policy, and practice management. Additionally, the journal''s Coding Corner offers professionals in GI practice answers to common coding and billing questions. Multimedia offerings include images, video abstracts, and podcasts. CGH also provides updates and commentary via Facebook, Twitter, LinkedIn, and its research blog The AGA Journals Blog. CGH is ranked 7th out of 78 journals in the Gastroenterology and Hepatology category on the 2015 Journal Citation Reports®, published by Thomson Reuters, and has an Impact Factor of 7.680. On average, authors receive decisions on their manuscripts in less than two weeks. CGH has an acceptance rate of 12% and is circulated to 20,300 individuals and institutions worldwide.
由爱思唯尔健康出版。ISSN: 1542 - 3565。 《临床胃肠病学与肝病》(CGH)的使命是为读者提供临床胃肠病学与肝病的广泛主题,包括癌症、炎症性疾病、功能性胃肠疾病、营养、吸收和分泌方面的诊断、内镜、介入和治疗进展。 这个同行评审的杂志包括原始文章和学术评论,目的是所有发表的文章将立即与胃肠病学和肝病学专业的实践相关。除了同行评审的文章外,该杂志还邀请了一些重要的评论和文章,内容涉及基于内镜/实践的技术、卫生保健政策和实践管理。此外,《华尔街日报》“s编码角落提供专业人士在胃肠道实践常见的编码和计费问题的答案。多媒体产品包括图像、视频摘要和播客。CGH还提供更新和评论通过Facebook、Twitter、LinkedIn、其研究博客博客AGA期刊。 CGH在汤森路透(Thomson Reuters) 2015年期刊引文报告(Citation Reports)®收录的78种胃肠病学和肝病类期刊中排名第七,影响因子为7.680。平均而言,作者在不到两周的时间内就能收到关于他们手稿的决定。CGH的录取率为12%,并在全球20,300个个人和机构中流通。
大类(学科) | 小类(学科) | 学科排名 |
医学 |
GASTROENTEROLOGY & HEPATOLOGY(肠胃学和肝脏学) 2区 |
7/80 |
年度总发文量 | 年度论文发表量 | 年度综述发表量 |
196 | 171 | 25 |
引文计数(2018)
文献(2015-2017)
5241次引用
1399篇文献
序号 | 类别 | 排名 | 百分位 |
1 |
大类(学科):Medicine
小类(学科):Hepatology
|
#9/59
点击查看排名表
|
|
2 |
大类(学科):Medicine
小类(学科):Gastroenterology
|
#17/128
点击查看排名表
|
|
推荐刊物均可到国家新闻出
版总署网站查询正刊
可签署保密协议 ,不透露任
何用户信息可跟踪进程,全程
协议
1对1服务,7x24小时在线
15年经验沉淀,实体公司
运营
liting7111
研究方向:消化病 胃肠道
审稿时间: 3个月内
liting7111
研究方向:消化病 胃肠道
接受率: 非常困难(几乎不命中)
影响因子:2.566
ISSN:0739-7240
研究方向:农林科学-奶制品与动物科学
影响因子:6.497
ISSN:1172-7047
研究方向:医学-精神病学
影响因子:1.297
ISSN:0028-2804
研究方向:医学-精神病学
影响因子:4.604
ISSN:1092-8529
研究方向:医学-精神病学
影响因子:5.345
ISSN:1398-5647
研究方向:医学-精神病学
影响因子:3.492
ISSN:1540-2002
研究方向:CLINICAL NEUROLOGY-PSYCHIATRY
影响因子:4.562
ISSN:0269-8811
研究方向:医学-精神病学
影响因子:6.533
ISSN:0165-0327
研究方向:医学-精神病学
影响因子:5.415
ISSN:0924-977X
研究方向:医学-精神病学
发表一篇学和医学成像类SCI论文
需要多少钱?
专注医学期刊服务15年
您好:请问您咨询什么等级的期刊?专注医学类期刊发表15年口碑企业,为您提供以下服务:
1.医学核心期刊发表-全流程服务
2.医学SCI期刊-全流程服务
3.论文投稿服务-快速报价
4.期刊推荐直至录用,不成功不收费
客服正在输入...
Clinical Gastroenterology and Hepatology 投稿经验
(由下方点评分析获得,2人参与,29708人阅读)